SCHEMBL1856101

SCHEMBL1856101

c1csc(C2=N[N]N=N2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.43
ALDH1A1 P00352 5/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
MAPT P10636 2/20 0.43
HPGD P15428 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2E1 P05181 1/20 0.39
CYP2A6 P11509 1/20 0.39
CYP2B6 P20813 1/20 0.39
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
HSD17B10 Q99714 3/20 0.38
POLB P06746 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL577392 0.80 CYP2E1 (0.43) KDM4EALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL3670584 0.74 KDM4E (0.43) KDM4EALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL5578345 0.70 KDM4E (0.48) KDM4EALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL16291133 0.69 L3MBTL1 (0.57) KDM4EALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL3545 0.69 L3MBTL1 (0.57) KDM4EALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL10730554 0.68 KDM4E (0.42) KDM4EALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL7227898 0.68 L3MBTL1 (0.50) KDM4EALDH1A1MEN1KMT2AL3MBTL1
Ammonia Solution, Strong SCHEMBL34467257 0.67 L3MBTL1 (0.55) KDM4EALDH1A1MEN1KMT2AL3MBTL1
Hydrogen Sulfide SCHEMBL22588115 0.67 L3MBTL1 (0.55) KDM4EALDH1A1MEN1KMT2AL3MBTL1
Fluoride SCHEMBL491501 0.67 L3MBTL1 (0.55) KDM4EALDH1A1MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2324016-B1 3-(N-HETEROCYCLYL)-PYRROLIDINYL-PHENYL-OXAZOLIDINONES AS ANTIBACTERIAL AGENTS FERRER INT (ES) 2012-04-25 EP claimed
JP-2011526590-A 2011-10-13 JP claimed
US-20110136829-A1 3-(N-HETEROCYCLYL)-PYRROLIDINYL-PHENYL-OXAZOLIDINONES AS ANTIBACTERIAL AGENTS FERRER INTERNACIONAL, S.A. (ES) 2011-06-09 US claimed
EP-2324016-A1 3-(N-HETEROCYCLYL)-PYRROLIDINYL-PHENYL-OXAZOLIDINONES AS ANTIBACTERIAL AGENTS Ferrer Internacional, S.A. (ES) 2011-05-25 EP claimed
WO-2010000704-A1 3-(N-HETEROCYCLYL)-PYRROLIDINYL-PHENYL-OXAZOLIDINONES AS ANTIBACTERIAL AGENTS FERRER INTERNACIONAL, S.A. (ES) 2010-01-07 WO claimed
EP-2141162-A1 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents Ferrer Internacional, S.A. (ES) 2010-01-06 EP claimed
EP-2324016-B1 3-(N-HETEROCYCLYL)-PYRROLIDINYL-PHENYL-OXAZOLIDINONES AS ANTIBACTERIAL AGENTS FERRER INT (ES) 2012-04-25 EP disclosed
US-20110136829-A1 3-(N-HETEROCYCLYL)-PYRROLIDINYL-PHENYL-OXAZOLIDINONES AS ANTIBACTERIAL AGENTS FERRER INTERNACIONAL, S.A. (ES) 2011-06-09 US disclosed
EP-2324016-A1 3-(N-HETEROCYCLYL)-PYRROLIDINYL-PHENYL-OXAZOLIDINONES AS ANTIBACTERIAL AGENTS Ferrer Internacional, S.A. (ES) 2011-05-25 EP disclosed
WO-2010000704-A1 3-(N-HETEROCYCLYL)-PYRROLIDINYL-PHENYL-OXAZOLIDINONES AS ANTIBACTERIAL AGENTS FERRER INTERNACIONAL, S.A. (ES) 2010-01-07 WO disclosed
EP-2141162-A1 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents Ferrer Internacional, S.A. (ES) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136829-A1 3-(N-HETEROCYCLYL)-PYRROLIDINYL-PHENYL-OXAZOLIDINONES AS ANTIBACTERIAL AGENTS OXA1L, MRPL21, RPL5 KDM4E 4055/4885ALDH1A1 1275/4885MEN1 3571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.